Antitumor activity of terpenoids against classical and atypical multidrug resistant cancer cells

Phytomedicine

Volumn 17, Issue 6, 2010, Pages 441-448

  Lage, H ^a   Duarte, N ^b   Coburger, C ^a,c   Hilgeroth, A ^c   Ferreira, M J U ^b  

^a Charité Campus Benjamin Franklin Medical Center   (Germany)

^b RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

^c MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Antiproliferative; Helioscopinolides; Lathyrane diterpenes; Multidrug resistance; Terpenoids

Indexed keywords

17 ACETOXY 16ALPHA HYDROXYATISAN 3 ONE; 17 ACETOXY 16ALPHA HYDROXYKAURAN 3 ONE; 3BETA ACETOXYHELIOSCOPINOLIDE B; 3BETA HYDROXY 20 TARAXASTEN 30 AL; 6BETA HYDROXYSITOSTENONE; 7 OXOSITOSTEROL; 7ALPHA HYDROXYSITOSTEROL; DAUNORUBICIN; DITERPENE; ENT 16ALPHA,17 DIHYDROXYATISAN 3 ONE; ENT 16ALPHA,17 DIHYDROXYKAURAN 3 ONE; ERGOSTEROL PEROXIDE; HELIOSCOPINOLIDE A; HELIOSCOPINOLIDE B; HELIOSCOPINOLIDE D; HELIOSCOPINOLIDE E; JOLKINOL B; LACTONE DERIVATIVE; LATILAGASCENE B; LATILAGASCENE C; LATILAGASCENE D; MITOXANTRONE; MULTIDRUG RESISTANCE PROTEIN 1; STEROID; STIGMASTANE 3,6 DIONE; TERPENOID; TRITERPENE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; MULTIDRUG RESISTANCE PROTEIN; PLANT EXTRACT; TERPENE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; COLON CARCINOMA; CONTROLLED STUDY; EUPHORBIA; HUMAN; HUMAN CELL; PANCREAS CARCINOMA; PRIORITY JOURNAL; STOMACH CARCINOMA; CARCINOMA; CELL PROLIFERATION; CHEMISTRY; COLONIC NEOPLASMS; DRUG EFFECTS; DRUG RESISTANCE; ISOLATION AND PURIFICATION; MULTIDRUG RESISTANCE; PANCREATIC NEOPLASMS; PHYTOTHERAPY; STOMACH NEOPLASMS; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; EUPHORBIA; HUMANS; P-GLYCOPROTEIN; PANCREATIC NEOPLASMS; PHYTOTHERAPY; PLANT EXTRACTS; STOMACH NEOPLASMS; TERPENES;

EUPHORBIA;

EID: 77950297689     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2009.07.009     Document Type: Article

References (29)

1. Borowski E., BontempsGracz M., and Piwkowska A. Strategies for overcoming ABC-transporters-mediated multidrug resistance (MDR) of tumor cells. Acta Biochim. Pol. 52 (2005) 609-627
2. Buck S.B., Hardouin C., Ichikawa S., Soenen D.R., Gauss C.M., Hwang I., Swingle M.R., Bonness K.M., Honkanen R.E., and Boger D.L. Fundamental role of the fostriecin unsaturated lactone and implications for selective protein phosphatase inhibition. J. Am. Chem. Soc. 125 (2003) 15694-15695
3. Chaurasia N., and Wichtl M. Sterols and steryl glycosides from Urtica dioica. J. Nat. Prod. 50 (1987) 881-885
4. Dai J., Zhao C., Zhang Q., Liu Z., and Yang L. Taraxastane-type triterpenoids from Saussurea petrovii. Phytochemistry 60 (2001) 1107-1111
5. In: Dewick P.M. (Ed). Medicinal Natural Products, a Biosynthetic Approach. 2nd Ed (2002), Wiley, England 191-212
6. Duarte N., Ferreira M.J., Martins M., Viveiros M., and Amaral L. Antibacterial activity of ergosterol peroxide against Mycobacterium tuberculosis. Dependence upon system and medium employed. Phytother. Res. 21 (2007) 601-604
7. Duarte N., Gyémánt N., Abreu P., Molnár J., and Ferreira M.J. New macrocyclic lathyrane diterpenes, from Euphorbia lagascae, as inhibitors of multidrug resistance of tumor cells. Planta Med. 72 (2006) 162-168
8. Duarte N., Lage H., and Ferreira M.J. Three new jatrophane diterpene polyesters and other constituents from Euphorbia tuckeyana. Planta Med. 74 (2008) 61-68
9. Duarte N., Varga A., Radics R., Molnár J., and Ferreira M.J. Apoptosis induction and modulation of P-glycoprotein mediated multidrug resistance by new macrocyclic lathyrane-type diterpenoids. Bioorg. Med. Chem. 15 (2007) 546-554
10. Fátima A., Modolo L.V., Conegero L.S., Pilli R.A., Ferreira C.V., Kohn L.K., and de Carvalho J.E. Styryl lactones and their derivatives: biological activities, mechanisms of action and potential leads for drug design. Curr. Med. Chem. 13 (2006) 3371-3384
11. Ferreira M.J., Gyémant N., Madureira A.M., Tanaka M., Koós K., Didziapetris R., and Molnár J. The effects of jatrophane derivatives on the reversion of MDR1 and MRP-mediated multidrug resistance in the MDA-MB-231 (HTB-26) cell line. Anticancer Res. 25 (2005) 4173-4178
12. Greca M., Monaco P., and Previtera L. Stigmasterols from Typha latifolia. J. Nat. Prod. 53 (1990) 1430-1435
13. König J., Hartel M., Nies A., Martignoni M., Guo J., Buchler M., et al. Expression and localization of human multidrug resistance protein (ABCC) family members in pancreatic carcinoma. Int. J. Cancer 115 (2005) 359-367
14. Lage H., Aki-Sener E., and Yalcin I. High antineoplastic activity of new heterocyclic compounds in cancer cells with resistance against classical DNA topoisomerase II-targeting drugs. Int. J. Cancer 119 (2006) 213-220
15. Lage H., and Dietel M. Multiple mechanisms confer different drug-resistant phenotypes in pancreatic carcinoma cells. J. Cancer Res. Clin. Oncol. 128 (2002) 349-357
16. Lage H. An overview of cancer multidrug resistance: a still unsolved problem. Cell. Mol. Life Sci. 65 (2008) 3145-3167
17. Lage H. Molecular analysis of therapy resistance in gastric cancer. Dig. Dis. 21 (2003) 326-338
18. Lim J., Park J., Budesinsky M., Kasal A., Han Y., Koo B., Lee S., and Lee D. Antimutagenic constituents from the thorns of Gleditsia sinensis. Chem. Pharm. Bull. 53 (2005) 561-564
19. Liu L.F., Rowe T.C., Yang L., Tewey K.M., and Chen G.L. Cleavage of DNA by mammalian DNA Topoisomerase II. J. Biol. Chem. 258 (1983) 15365-15370
20. Materna V., Pleger J., Hoffmann U., and Lage H. RNA expression of MDR1/P-glycoprotein, DNA-topoisomerase I, and MRP2 in ovarian carcinoma patients: correlation with chemotherapeutic response. Gynecol. Oncol. 94 (2004) 152-160
21. Nieth C., and Lage H. Induction of the ABC-transporters MDR1/P-gp (Abcb1), MRP1 (Abcc1), and BCRP (Abcg2) during establishment of multidrug resistance following exposure to mitoxantrone. J. Chemother. 17 (2005) 215-223
22. Pettit G., Numata A., Cragg G., Herald D., Takada T., Iwamoto C., et al. Isolation and structures of schleicherastatins 1-7 and schleicheols 1 and 2 from the teak forest medicinal tree Schleichera oleosa. J. Nat. Prod. 63 (2000) 72-78
23. Sinha P., Hütter G., Köttgen E., Dietel M., Schadendorf D., and Lage H. Search for novel proteins involved in the development of chemoresistance in colorectal cancer and fibrosarcoma cells in vitro using two-dimensional electrophoresis, mass spectrometry and microsequencing. Electrophoresis 20 (1999) 2961-2969
24. Speroni E., Coletti B., Minghetti A., Perellino N., Guicciardi A., and Vincieri F. Activity on the CNS of crude extracts and of some diterpenoids isolated from Euphorbia calyptrata suspended cultures. Planta Med. 57 (1991) 531-535
25. Szakács G., Paterson J., Ludwig J., Genthe C., and Gottesman M. Targeting multidrug resistance in cancer. Nat. Rev. Drug Discov. 5 (2006) 219-234
26. Teodori E., Dei S., Martelli C., Scapecchi C., and Gualtieri F. The functions and structure of ABC transporters: implications for the design of new inhibitors of Pgp and MRP1 to control multidrug resistance (MDR). Curr. Drug Targets 7 (2006) 893-909
27. 13C NMR assignments of two phytosterols from roots of Piper nigrum. Magn. Reson. Chem. 42 (2004) 355-359
28. Wesolowska O., Wiśniewski J., Duarte N., Ferreira M.J., and Michalak K. Inhibition of MRP1 transport activity by phenolic and terpenic compounds isolated from Euphorbia species. Anticancer Res. 27 (2007) 4127-4134
29. Zhang S., Won Y.K., Ong C.N., and Shen H.M. Anti-cancer potential of sesquiterpene lactones: bioactivity and molecular mechanisms. Curr. Med. Chem. Anticancer Agents. 5 (2005) 239-249